Less is more in the case of this cancer treatment. The most common form of cancer among men in the US, after skin cancer, ...

TEM is integrating externally developed AI pathology into its ecosystem to improve risk prediction and personalize prostate ...

A new blood test could help doctors identify whether a treatment for advanced prostate cancer is failing weeks earlier than ...

Prostate cancer is one of the top diagnoses for men with cancer, but early stages are tough to detect. “You know, maybe some ...

Men given two larger doses of radiation had about the same side effects as others treated with the standard five-dose course, ...

An investigator presented extended follow-up data from a phase 3 trial on aglatimagene besadenovec (CAN-2409) + prodrug in combination with standard-of-care EBRT in men with localized prostate cancer.

Tempus AI, Inc., a leader in artificial intelligence and precision medicine, today announced the clinical launch of the ArteraAI Prostate Test (mHSPC). The CLIA-certified and CAP-accredited prognostic ...

Radiation therapy (also called radiotherapy) uses high-energy beams or subatomic particles to damage the DNA inside prostate cancer cells. After enough damage, the cells cannot multiply, and they die.

Chief Executive Officer Dr. Paul Peter Tak said the company remains focused on advancing its viral immunotherapy programs ...

Metastatic prostate cancer is cancer that began in the prostate but has spread to other parts of the body. There's no cure, but there are a number of effective treatments you can discuss with a ...

Testosterone replacement therapy improved function without PSA recurrence in prostate cancer survivors with hypogonadism.

In prostate cancer, hormone therapy is treatment to keep the cancer cells from getting testosterone, the main male hormone (androgen). Hormone therapy for prostate cancer is also called ...